Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,973.0
24.0 (0.81%)

 

  • STI Straits Times Index
    2,973.0
    24.0 (0.81%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,567.1
    -10.6 (-0.67%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,452.6
    472.4 (1.63%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,551.4
    42.3 (1.21%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,663.5
    697.5 (2.41%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,338.5
    96.7 (1.55%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,925.5M
  • Value: 1,621.8M
  • Rise: 184
  • Fall: 171
  • Unch: 419

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.072+0.001
CWX Global0.006-0.001
Thomson Medical0.121+0.002
Jiutian Chemical0.090+0.001
Sembcorp Marine0.153-
YZJ Shipbldg SGD1.080+0.010
Avarga0.325-0.040
Shen Yao0.003-0.001
Jasper Inv0.006-
Secura0.100-0.002

World Indices

World Indices
Name Last Change
Nasdaq 13,192.3 +72.9
HSI 29,452.6 +472.4
HSCEI 11,453.7 +206.5
Jakarta 6,338.5 +96.7
Nikkei 225 29,663.5 +697.5
SSE Comp 3,551.4 +42.3
Shanghai A 3,722.6 +44.4
Shanghai B 246.1 +2.8
KOSPI 3,099.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

JACOBIO-B JACOBIO-B
Quotes 15 Minutes Delayed. Updated at 01 Mar 2021 16:08
Last (HKD): 20.150 Change: +0.150 High: 21.000 Remarks: -
Change (%): +0.75 Low: 20.000
Open 20.300 Yesterday's Close 20.000
Buy Price 20.150 Sell Price 20.400
Buy Volume ('000) 1.8 Sell Volume ('000) 0.3
Cumulative Volume ('000) 246.6 Cumulative Value 5,005,530
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a -0.62440 Trailing EPS (HKD) e -1.55048 NAV (HKD) b -1.8224
PE a - Trailing PE f - Price / NAV b -11.0568
Dividend (HKD) d - Cash In Hand (HKD) g 0.5759 Issued & Paid-up Shares c 771,462,000
Dividend Yield (%) d - Price / Cash In Hand g 34.989 Treasury Shares h -
Beta - 75 Daysi 1.357 R-Squared - 75 Days(%)i 13.35 Market Cap (M) 15,544.959
Beta - 500 Daysi 1.296 R-Squared - 500 Days (%)i 13.96 Enterprise Value (M) 16,972.518
Piotroski F Score 2 Exchange Code 1167 Par Value ( USD ) 0.00010
52 Weeks Volatility (%) n.a. 6-Month VWAP n.a. Free Float (%) 23.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 Jan 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 14 Dec 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference JACOBIO-B HKEx 15,544.959 - - -11.0568 -
Industry Biotechnology HKEx 49,429.405 - - 11.5295 0.110
Local Peer WUXI BIO HKEx 430,698.345 374.657 299.115 28.8323 -
Local Peer BEIGENE HKEx 234,504.324 - - - -
Local Peer SINO BIOPHARM HKEx 163,115.932 53.145 63.741 4.5258 0.615
Local Peer ZAI LAB-SB HKEx 100,787.709 - - 27.9378 -
Local Peer JOINN HKEx 37,773.782 177.348 154.785 34.2004 -
Local Peer GENSCRIPT BIO HKEx 29,084.523 - - 3.9779 -
Local Peer 3SBIO HKEx 20,425.108 18.499 13.603 1.7461 -
Local Peer JW THERAP-B HKEx 16,594.936 - - -16.3743 -
Local Peer VIVA BIOTECH HKEx 13,222.608 43.860 - 6.3559 0.236
Local Peer ALPHAMAB-B HKEx 12,883.459 - - 4.5500 -
Local Peer HAOHAI BIOTEC HKEx 10,973.695 26.101 45.886 1.8027 1.241
Local Peer FRONTAGE HKEx 10,566.803 73.171 99.999 5.0097 -
Other Local Peers JHBP-B (HKEx), ASCENTAGE-B (HKEx), KINTOR PHARMA-B (HKEx), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), REGENT PACIFIC (HKEx), CT ENTERPRISE (HKEx)
Global Peer AMGEN INC NASDAQ 129,906.145 17.884 17.884 13.8066 2.849
Global Peer CSL LTD ASX 122,980.643 39.212 32.314 11.6378 1.086
Global Peer GILEAD SCIENCES INC NASDAQ 77,154.626 627.299 627.273 4.2388 4.421
Global Peer ILLUMINA INC NASDAQ 64,109.919 97.729 97.729 13.6579 -
Global Peer MODERNA INC NASDAQ 61,259.865 - - 23.9166 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 55,254.498 20.377 20.377 6.3607 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 48,270.452 13.740 13.740 4.3782 -
Global Peer BIOGEN INC NASDAQ 41,569.448 10.391 10.391 3.8849 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 33,581.782 55.654 55.654 2.8823 -
Global Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 29,272.000 - - 6.8273 -
Other Global Peers SEAGEN INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), NOVAVAX INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), BIO-TECHNE CORP (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), KODIAK SCIENCES INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), BEAM THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), Lonza (SGX), PTC THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ARVINAS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ALKERMES PLC (NASDAQ), SEER INC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), XENCOR INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), LIGAND PHARMACEUTICAL INC (NASDAQ), ALLOVIR INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NUVATION BIO INC (NYSE), KYMERA THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), OCUGEN INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), DICERNA PHARMACEUTICALS INC. (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOATLA INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), TRANSLATE BIO INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), PRECIGEN INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), UNIQURE N.V. (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), NKARTA INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), MACROGENICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), POLYNOVO LIMITED (ASX), VAXCYTE INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MORPHIC HOLDING INC (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), MESOBLAST LTD (ASX), MIMEDX GROUP INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VANDA PHARMACE INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), EPIZYME INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), HUMANIGEN INC (NASDAQ), INHIBRX INC (NASDAQ), PASSAGE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PROTHENA CORP PLC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), CHIMERIX INC (NASDAQ), MERUS B V (NASDAQ), CURIS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), VBI VACCINES INC CDA (NASDAQ), ATHIRA PHARMA INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), COMPUGEN (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), AKOUOS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), IMMATICS N V (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), AFFIMED N V (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), MEIRAGTX HOLDINGS PLC (NASDAQ), ATRECA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ALTIMMUNE INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ARDELYX INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), GERON CORP (NASDAQ), IVERIC BIO INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), DPHARMA (Bursa), AKEBIA THERAPEUTICS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), BIOVIE INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), IMMUNOME INC (NASDAQ), OPTHEA LIMITED (ASX), PORTAGE BIOTECH INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ONCORUS INC (NASDAQ), ATHERSYS INC (NASDAQ), XOMA CORP (NASDAQ), VERASTEM INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IMUGENE LIMITED (ASX), FORTE BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), SURFACE ONCOLOGY INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), PARATEK PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ANTEOTECH LIMITED (ASX), 9 METERS BIOPHARMA INC (NASDAQ), TREVENA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), NEXTCURE INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), MEDICINOVA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), NANOVIRICIDES INC (NYSE American), LARIMAR THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CHIASMA INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IMV INC (NASDAQ), METACRINE INC (NASDAQ), BIONOMICS LTD (ASX), ADMA BIOLOGICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EQUILLIUM INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), CATALYST BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), IMMUTEP LTD (ASX), ENOCHIAN BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CEL-SCI CORP (NYSE American), IDERA PHARMACEUTICALS INC (NASDAQ), IBIO INC (NYSE American), AZIYO BIOLOGICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), LONGEVERON INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CONTRAFECT CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), ENZO BIOCHEM INC (NYSE), LEAP THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), GALECTIN THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), AIKIDO PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), LUMOS PHARMA INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CIDARA THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ADVAXIS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), SAVARA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), ORGANOVO HLDGS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), LEAF RESOURCES LTD (ASX), VASCULAR BIOGENICS LTD (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), WINDTREE THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CHIMERIC THERAPEUTICS LTD (ASX), AZURRX BIOPHARMA INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), GENETIC TECHNOLOGIES (ASX), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MEMPHASYS LTD (ASX), CATABASIS PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), KIROMIC BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), NABRIVA THERAPEUTICS PLC (NASDAQ), ORAGENICS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), PRECIPIO INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), BIOTRON (ASX), CYCLACEL PHARMACEUTICALS INC (NASDAQ), PATRYS LIMITED (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), Suntar Eco-City (SGX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), HISTOGEN INC (NASDAQ), GEOVAX LABS INC (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), CONSTELLATION TECHNOLOGIES LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENESTECH INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), NANOLLOSE LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.850
-12.39 %
10 Days --1.350
-6.28 %
20 Days --1.100
-5.18 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 13.000 - 25.350 Change From 1 Year Low +7.150 % Change From 1 Year Low (%) +55.00
Change From 1 Year High -5.200 % Change From 1 Year High (%) -20.51
2 Years Range 13.000 - 25.350 Change From 2 Years Low +7.150 % Change From 2 Years Low (%) +55.00
Change From 2 Years High -5.200 % Change From 2 Years High (%) -20.51
5 Years Range 13.000 - 25.350 Change From 5 Years Low +7.150 % Change From 5 Years Low (%) +55.00
Change From 5 Years High -5.200 % Change From 5 Years High (%) -20.51
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Jacobio Pharmaceuticals Group Co., Ltd. operates as an investment holding company which engages in research and development of new drugs. It focuses on developing small-molecule drugs to modulate enzymes by binding to their allosteric sites in order to address previously “undruggable” targets such as protein tyrosine phosphatases (PTPs) and KRAS. The company was founded by Yin Xiang Wang on July 1, 2018 and is headquartered in Beijing, China.

Historical Price Data

Date Open High Low Close Volume VWAP